Friday

29th Mar 2024

Ticker

EU medicines agency needs more time to assess Brexit impact

The European Medicines Agency (EMA) is "currently finalising" a report on how relocation after Brexit will affect the currently London-based agency, a spokeswoman told EUobserver. The European Parliament adopted a text earlier this year saying "an impact assessment including remedial solutions should be available by the end of the first quarter of 2017" – eleven weeks ago. The EMA said it will not make the impact assessment public.

Read and decide

Join EUobserver today

Get the EU news that really matters

Instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

Opinion

EU Modernisation Fund: an open door for fossil gas in Romania

Among the largest sources of financing for energy transition of central and eastern European countries, the €60bn Modernisation Fund remains far from the public eye. And perhaps that's one reason it is often used for financing fossil gas projects.

'Swiftly dial back' interest rates, ECB told

Italian central banker Piero Cipollone in his first monetary policy speech since joining the ECB's board in November, said that the bank should be ready to "swiftly dial back our restrictive monetary policy stance."

Join EUobserver

EU news that matters

Join us